APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Constipation Nutraceuticals

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Constipation Nutraceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173980640331 December 2025198 pages

Choose your research edition.

Industry ResearchConstipation Nutraceuticals Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Constipation Nutraceuticals Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Constipation Nutraceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Constipation Nutraceuticals Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Constipation Nutraceuticals Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Constipation Nutraceuticals market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Constipation Nutraceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Constipation Nutraceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Constipation Nutraceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Constipation Nutraceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Constipation Nutraceuticals include Tate & Lyle, Kerry Group, Ingredion Incorporated, Glanbia, DuPont, DSM, Chr. Hansen Holding, Cargill and BASF, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Constipation Nutraceuticals market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Constipation Nutraceuticals and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Constipation Nutraceuticals sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Constipation Nutraceuticals market size, projected growth trends, production technologies, key applications, and end-use industries.

Constipation Nutraceuticals Segment by Company

Tate & Lyle

Kerry Group

Ingredion Incorporated

Glanbia

DuPont

DSM

Chr. Hansen Holding

Cargill

BASF

Associated British Foods

Arla Foods

Ajinomoto Group

ADM

Constipation Nutraceuticals Segment by Type

Omega-3 Fatty Acids

Amino Acids and Proteins

Minerals

Carotenoids

Vitamins

Fibers and Specialty Carbohydrates

Prebiotics and Probiotics

Others

Constipation Nutraceuticals Segment by Application

Adult

Child

Constipation Nutraceuticals Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Constipation Nutraceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Constipation Nutraceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Constipation Nutraceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Constipation Nutraceuticals market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Constipation Nutraceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Constipation Nutraceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Constipation Nutraceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Constipation Nutraceuticals Industry Trends Table 2. Constipation Nutraceuticals Industry Drivers Table 3. Constipation Nutraceuticals Industry Opportunities and Challenges Table 4. Constipation Nutraceuticals Industry Restraints Table 5. Global Constipation Nutraceuticals Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Constipation Nutraceuticals Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Constipation Nutraceuticals Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Constipation Nutraceuticals Sales Market Share by Manufacturers Table 9. Global Constipation Nutraceuticals Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Constipation Nutraceuticals Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Constipation Nutraceuticals Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Constipation Nutraceuticals Manufacturers, Product Type & Application Table 13. Global Constipation Nutraceuticals Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Constipation Nutraceuticals by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Omega-3 Fatty Acids Table 17. Major Manufacturers of Amino Acids and Proteins Table 18. Major Manufacturers of Minerals Table 19. Major Manufacturers of Carotenoids Table 20. Major Manufacturers of Vitamins Table 21. Major Manufacturers of Fibers and Specialty Carbohydrates Table 22. Major Manufacturers of Prebiotics and Probiotics Table 23. Major Manufacturers of Others Table 24. Global Constipation Nutraceuticals Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Constipation Nutraceuticals Sales by Type (2021-2026) & (K Units) Table 26. Global Constipation Nutraceuticals Sales by Type (2027-2032) & (K Units) Table 27. Global Constipation Nutraceuticals Sales Market Share by Type (2021-2026) Table 28. Global Constipation Nutraceuticals Sales Market Share by Type (2027-2032) Table 29. Global Constipation Nutraceuticals Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 30. Global Constipation Nutraceuticals Revenue by Type (2021-2026) & (K Units) Table 31. Global Constipation Nutraceuticals Revenue by Type (2027-2032) & (K Units) Table 32. Global Constipation Nutraceuticals Revenue Market Share by Type (2021-2026) Table 33. Global Constipation Nutraceuticals Revenue Market Share by Type (2027-2032) Table 34. Major Manufacturers of Adult Table 35. Major Manufacturers of Child Table 36. Global Constipation Nutraceuticals Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Constipation Nutraceuticals Sales by Application (2021-2026) & (K Units) Table 38. Global Constipation Nutraceuticals Sales by Application (2027-2032) & (K Units) Table 39. Global Constipation Nutraceuticals Sales Market Share by Application (2021-2026) Table 40. Global Constipation Nutraceuticals Sales Market Share by Application (2027-2032) Table 41. Global Constipation Nutraceuticals Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Constipation Nutraceuticals Revenue by Application (2021-2026) & (K Units) Table 43. Global Constipation Nutraceuticals Revenue by Application (2027-2032) & (K Units) Table 44. Global Constipation Nutraceuticals Revenue Market Share by Application (2021-2026) Table 45. Global Constipation Nutraceuticals Revenue Market Share by Application (2027-2032) Table 46. Global Constipation Nutraceuticals Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Constipation Nutraceuticals Sales by Region (2021-2026) & (K Units) Table 48. Global Constipation Nutraceuticals Sales Market Share by Region (2021-2026) Table 49. Global Constipation Nutraceuticals Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Constipation Nutraceuticals Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Constipation Nutraceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Constipation Nutraceuticals Sales by Country (2021-2026) & (K Units) Table 53. North America Constipation Nutraceuticals Sales by Country (2027-2032) & (K Units) Table 54. Europe Constipation Nutraceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Constipation Nutraceuticals Sales by Country (2021-2026) & (K Units) Table 56. Europe Constipation Nutraceuticals Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Constipation Nutraceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Constipation Nutraceuticals Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Constipation Nutraceuticals Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Constipation Nutraceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Constipation Nutraceuticals Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Constipation Nutraceuticals Sales by Country (2027-2032) & (K Units) Table 63. Global Constipation Nutraceuticals Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Constipation Nutraceuticals Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Constipation Nutraceuticals Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Constipation Nutraceuticals Revenue Market Share by Region (2021-2026) Table 67. Global Constipation Nutraceuticals Revenue Market Share by Region (2027-2032) Table 68. Tate & Lyle Company Information Table 69. Tate & Lyle Business Overview Table 70. Tate & Lyle Constipation Nutraceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Tate & Lyle Constipation Nutraceuticals Product Portfolio Table 72. Tate & Lyle Recent Development Table 73. Kerry Group Company Information Table 74. Kerry Group Business Overview Table 75. Kerry Group Constipation Nutraceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Kerry Group Constipation Nutraceuticals Product Portfolio Table 77. Kerry Group Recent Development Table 78. Ingredion Incorporated Company Information Table 79. Ingredion Incorporated Business Overview Table 80. Ingredion Incorporated Constipation Nutraceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Ingredion Incorporated Constipation Nutraceuticals Product Portfolio Table 82. Ingredion Incorporated Recent Development Table 83. Glanbia Company Information Table 84. Glanbia Business Overview Table 85. Glanbia Constipation Nutraceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Glanbia Constipation Nutraceuticals Product Portfolio Table 87. Glanbia Recent Development Table 88. DuPont Company Information Table 89. DuPont Business Overview Table 90. DuPont Constipation Nutraceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. DuPont Constipation Nutraceuticals Product Portfolio Table 92. DuPont Recent Development Table 93. DSM Company Information Table 94. DSM Business Overview Table 95. DSM Constipation Nutraceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. DSM Constipation Nutraceuticals Product Portfolio Table 97. DSM Recent Development Table 98. Chr. Hansen Holding Company Information Table 99. Chr. Hansen Holding Business Overview Table 100. Chr. Hansen Holding Constipation Nutraceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Chr. Hansen Holding Constipation Nutraceuticals Product Portfolio Table 102. Chr. Hansen Holding Recent Development Table 103. Cargill Company Information Table 104. Cargill Business Overview Table 105. Cargill Constipation Nutraceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Cargill Constipation Nutraceuticals Product Portfolio Table 107. Cargill Recent Development Table 108. BASF Company Information Table 109. BASF Business Overview Table 110. BASF Constipation Nutraceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. BASF Constipation Nutraceuticals Product Portfolio Table 112. BASF Recent Development Table 113. Associated British Foods Company Information Table 114. Associated British Foods Business Overview Table 115. Associated British Foods Constipation Nutraceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Associated British Foods Constipation Nutraceuticals Product Portfolio Table 117. Associated British Foods Recent Development Table 118. Arla Foods Company Information Table 119. Arla Foods Business Overview Table 120. Arla Foods Constipation Nutraceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Arla Foods Constipation Nutraceuticals Product Portfolio Table 122. Arla Foods Recent Development Table 123. Ajinomoto Group Company Information Table 124. Ajinomoto Group Business Overview Table 125. Ajinomoto Group Constipation Nutraceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Ajinomoto Group Constipation Nutraceuticals Product Portfolio Table 127. Ajinomoto Group Recent Development Table 128. ADM Company Information Table 129. ADM Business Overview Table 130. ADM Constipation Nutraceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. ADM Constipation Nutraceuticals Product Portfolio Table 132. ADM Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Constipation Nutraceuticals Distributors List Table 136. Constipation Nutraceuticals Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Constipation Nutraceuticals Product Image Figure 2. Global Constipation Nutraceuticals Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Constipation Nutraceuticals Market Size (2021-2032) & (US$ Million) Figure 4. Global Constipation Nutraceuticals Sales (2021-2032) & (K Units) Figure 5. Global Constipation Nutraceuticals Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Constipation Nutraceuticals Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Omega-3 Fatty Acids Image Figure 9. Amino Acids and Proteins Image Figure 10. Minerals Image Figure 11. Carotenoids Image Figure 12. Vitamins Image Figure 13. Fibers and Specialty Carbohydrates Image Figure 14. Prebiotics and Probiotics Image Figure 15. Others Image Figure 16. Global Constipation Nutraceuticals Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Constipation Nutraceuticals Sales Market Share 2021 VS 2025 VS 2032 Figure 18. Global Constipation Nutraceuticals Sales Market Share by Type (2021-2032) Figure 19. Global Constipation Nutraceuticals Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Constipation Nutraceuticals Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Constipation Nutraceuticals Revenue Market Share by Type (2021-2032) Figure 22. Adult Image Figure 23. Child Image Figure 24. Global Constipation Nutraceuticals Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Constipation Nutraceuticals Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Constipation Nutraceuticals Sales Market Share by Application (2021-2032) Figure 27. Global Constipation Nutraceuticals Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Constipation Nutraceuticals Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Constipation Nutraceuticals Revenue Market Share by Application (2021-2032) Figure 30. North America Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Constipation Nutraceuticals Sales Market Share by Country (2021-2032) Figure 32. U.S. Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Constipation Nutraceuticals Sales Market Share by Country (2021-2032) Figure 37. Germany Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Constipation Nutraceuticals Sales Market Share by Country (2021-2032) Figure 44. China Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Constipation Nutraceuticals Sales Market Share by Country (2021-2032) Figure 52. Brazil Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Constipation Nutraceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Constipation Nutraceuticals Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Constipation Nutraceuticals Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Constipation Nutraceuticals Revenue (2021-2032) & (US$ Million) Figure 63. North America Constipation Nutraceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Constipation Nutraceuticals Revenue (2021-2032) & (US$ Million) Figure 65. Europe Constipation Nutraceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Constipation Nutraceuticals Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Constipation Nutraceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Constipation Nutraceuticals Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Constipation Nutraceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Constipation Nutraceuticals Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Constipation Nutraceuticals Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Omega-3 Fatty Acids
  • Amino Acids and Proteins
  • Minerals
  • Carotenoids
  • Vitamins
  • Fibers and Specialty Carbohydrates
  • Prebiotics and Probiotics
  • Others
Applications
  • Adult
  • Child
Companies covered
  • Tate & Lyle
  • Kerry Group
  • Ingredion Incorporated
  • Glanbia
  • DuPont
  • DSM
  • Chr. Hansen Holding
  • Cargill
  • BASF
  • Associated British Foods
  • Arla Foods
  • Ajinomoto Group
  • ADM

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Constipation Nutraceuticals Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Constipation Nutraceuticals Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Constipation Nutraceuticals Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Constipation Nutraceuticals Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Constipation Nutraceuticals Market Dynamics
  1. 2.1 Constipation Nutraceuticals Industry Trends
  2. 2.2 Constipation Nutraceuticals Industry Drivers
  3. 2.3 Constipation Nutraceuticals Industry Opportunities and Challenges
  4. 2.4 Constipation Nutraceuticals Industry Restraints
3 Constipation Nutraceuticals Market by Manufacturers
  1. 3.1 Global Constipation Nutraceuticals Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Constipation Nutraceuticals Sales by Manufacturers (2021-2026)
  3. 3.3 Global Constipation Nutraceuticals Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Constipation Nutraceuticals Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Constipation Nutraceuticals Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Constipation Nutraceuticals Manufacturers, Product Type & Application
  7. 3.7 Global Constipation Nutraceuticals Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Constipation Nutraceuticals Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Constipation Nutraceuticals Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Constipation Nutraceuticals Tier 1, Tier 2, and Tier 3
4 Constipation Nutraceuticals Market by Type
  1. 4.1 Constipation Nutraceuticals Type Introduction
  2. 4.1.1 Omega-3 Fatty Acids
  3. 4.1.2 Amino Acids and Proteins
  4. 4.1.3 Minerals
  5. 4.1.4 Carotenoids
  6. 4.1.5 Vitamins
  7. 4.1.6 Fibers and Specialty Carbohydrates
  8. 4.1.7 Prebiotics and Probiotics
  9. 4.1.8 Others
  10. 4.2 Global Constipation Nutraceuticals Sales by Type
  11. 4.2.1 Global Constipation Nutraceuticals Sales by Type (2021 VS 2025 VS 2032)
  12. 4.2.2 Global Constipation Nutraceuticals Sales by Type (2021-2032)
  13. 4.2.3 Global Constipation Nutraceuticals Sales Market Share by Type (2021-2032)
  14. 4.3 Global Constipation Nutraceuticals Revenue by Type
  15. 4.3.1 Global Constipation Nutraceuticals Revenue by Type (2021 VS 2025 VS 2032)
  16. 4.3.2 Global Constipation Nutraceuticals Revenue by Type (2021-2032)
  17. 4.3.3 Global Constipation Nutraceuticals Revenue Market Share by Type (2021-2032)
5 Constipation Nutraceuticals Market by Application
  1. 5.1 Constipation Nutraceuticals Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Child
  4. 5.2 Global Constipation Nutraceuticals Sales by Application
  5. 5.2.1 Global Constipation Nutraceuticals Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Constipation Nutraceuticals Sales by Application (2021-2032)
  7. 5.2.3 Global Constipation Nutraceuticals Sales Market Share by Application (2021-2032)
  8. 5.3 Global Constipation Nutraceuticals Revenue by Application
  9. 5.3.1 Global Constipation Nutraceuticals Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Constipation Nutraceuticals Revenue by Application (2021-2032)
  11. 5.3.3 Global Constipation Nutraceuticals Revenue Market Share by Application (2021-2032)
6 Global Constipation Nutraceuticals Sales by Region
  1. 6.1 Global Constipation Nutraceuticals Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Constipation Nutraceuticals Sales by Region (2021-2032)
  3. 6.2.1 Global Constipation Nutraceuticals Sales by Region (2021-2026)
  4. 6.2.2 Global Constipation Nutraceuticals Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Constipation Nutraceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Constipation Nutraceuticals Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Constipation Nutraceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Constipation Nutraceuticals Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Constipation Nutraceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Constipation Nutraceuticals Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Constipation Nutraceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Constipation Nutraceuticals Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Constipation Nutraceuticals Revenue by Region
  1. 7.1 Global Constipation Nutraceuticals Revenue by Region
  2. 7.1.1 Global Constipation Nutraceuticals Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Constipation Nutraceuticals Revenue by Region (2021-2026)
  4. 7.1.3 Global Constipation Nutraceuticals Revenue by Region (2027-2032)
  5. 7.1.4 Global Constipation Nutraceuticals Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Constipation Nutraceuticals Revenue (2021-2032)
  8. 7.2.2 North America Constipation Nutraceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Constipation Nutraceuticals Revenue (2021-2032)
  11. 7.3.2 Europe Constipation Nutraceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Constipation Nutraceuticals Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Constipation Nutraceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Constipation Nutraceuticals Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Constipation Nutraceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Tate & Lyle
  2. 8.1.1 Tate & Lyle Company Information
  3. 8.1.2 Tate & Lyle Business Overview
  4. 8.1.3 Tate & Lyle Constipation Nutraceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Tate & Lyle Constipation Nutraceuticals Product Portfolio
  6. 8.1.5 Tate & Lyle Recent Developments
  7. 8.2 Kerry Group
  8. 8.2.1 Kerry Group Company Information
  9. 8.2.2 Kerry Group Business Overview
  10. 8.2.3 Kerry Group Constipation Nutraceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Kerry Group Constipation Nutraceuticals Product Portfolio
  12. 8.2.5 Kerry Group Recent Developments
  13. 8.3 Ingredion Incorporated
  14. 8.3.1 Ingredion Incorporated Company Information
  15. 8.3.2 Ingredion Incorporated Business Overview
  16. 8.3.3 Ingredion Incorporated Constipation Nutraceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ingredion Incorporated Constipation Nutraceuticals Product Portfolio
  18. 8.3.5 Ingredion Incorporated Recent Developments
  19. 8.4 Glanbia
  20. 8.4.1 Glanbia Company Information
  21. 8.4.2 Glanbia Business Overview
  22. 8.4.3 Glanbia Constipation Nutraceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Glanbia Constipation Nutraceuticals Product Portfolio
  24. 8.4.5 Glanbia Recent Developments
  25. 8.5 DuPont
  26. 8.5.1 DuPont Company Information
  27. 8.5.2 DuPont Business Overview
  28. 8.5.3 DuPont Constipation Nutraceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 DuPont Constipation Nutraceuticals Product Portfolio
  30. 8.5.5 DuPont Recent Developments
  31. 8.6 DSM
  32. 8.6.1 DSM Company Information
  33. 8.6.2 DSM Business Overview
  34. 8.6.3 DSM Constipation Nutraceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 DSM Constipation Nutraceuticals Product Portfolio
  36. 8.6.5 DSM Recent Developments
  37. 8.7 Chr. Hansen Holding
  38. 8.7.1 Chr. Hansen Holding Company Information
  39. 8.7.2 Chr. Hansen Holding Business Overview
  40. 8.7.3 Chr. Hansen Holding Constipation Nutraceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Chr. Hansen Holding Constipation Nutraceuticals Product Portfolio
  42. 8.7.5 Chr. Hansen Holding Recent Developments
  43. 8.8 Cargill
  44. 8.8.1 Cargill Company Information
  45. 8.8.2 Cargill Business Overview
  46. 8.8.3 Cargill Constipation Nutraceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cargill Constipation Nutraceuticals Product Portfolio
  48. 8.8.5 Cargill Recent Developments
  49. 8.9 BASF
  50. 8.9.1 BASF Company Information
  51. 8.9.2 BASF Business Overview
  52. 8.9.3 BASF Constipation Nutraceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BASF Constipation Nutraceuticals Product Portfolio
  54. 8.9.5 BASF Recent Developments
  55. 8.10 Associated British Foods
  56. 8.10.1 Associated British Foods Company Information
  57. 8.10.2 Associated British Foods Business Overview
  58. 8.10.3 Associated British Foods Constipation Nutraceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Associated British Foods Constipation Nutraceuticals Product Portfolio
  60. 8.10.5 Associated British Foods Recent Developments
  61. 8.11 Arla Foods
  62. 8.11.1 Arla Foods Company Information
  63. 8.11.2 Arla Foods Business Overview
  64. 8.11.3 Arla Foods Constipation Nutraceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Arla Foods Constipation Nutraceuticals Product Portfolio
  66. 8.11.5 Arla Foods Recent Developments
  67. 8.12 Ajinomoto Group
  68. 8.12.1 Ajinomoto Group Company Information
  69. 8.12.2 Ajinomoto Group Business Overview
  70. 8.12.3 Ajinomoto Group Constipation Nutraceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Ajinomoto Group Constipation Nutraceuticals Product Portfolio
  72. 8.12.5 Ajinomoto Group Recent Developments
  73. 8.13 ADM
  74. 8.13.1 ADM Company Information
  75. 8.13.2 ADM Business Overview
  76. 8.13.3 ADM Constipation Nutraceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ADM Constipation Nutraceuticals Product Portfolio
  78. 8.13.5 ADM Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Constipation Nutraceuticals Value Chain Analysis
  2. 9.1.1 Constipation Nutraceuticals Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Constipation Nutraceuticals Production Mode & Process
  6. 9.2 Constipation Nutraceuticals Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Constipation Nutraceuticals Distributors
  9. 9.2.3 Constipation Nutraceuticals Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst